{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T17:47:17Z","timestamp":1792086437824,"version":"4.4.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,5,12]],"date-time":"2017-05-12T00:00:00Z","timestamp":1494547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,5,12]],"date-time":"2017-05-12T00:00:00Z","timestamp":1494547200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sig Transduct Target Ther"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Vascular endothelial growth factor (VEGF), one of the most important angiogenic factors, plays an essential role in both physiological and pathological angiogenesis through binding to VEGF receptors (VEGFRs). Here we report a novel peptide designated HRHTKQRHTALH (peptide HRH), which was isolated from the Ph.D. -12 phage display library using VEGFR-Fc fusion protein as the bait. This peptide was found to dose-dependently inhibit the proliferation of human umbilical vein endothelial cells stimulated by VEGF. The anti-angiogenesis effect of the HRH peptide was further confirmed <jats:italic>in vivo<\/jats:italic> using the chick chorioallantoic membrane assay, which was also dose-dependent. Besides, peptide HRH was proved to inhibit corneal neovascularization in an alkali-burnt rat corneal model and a suture-induced rat corneal model. Taken together, these findings suggest that the HRH peptide can inhibit angiogenesis both <jats:italic>in vitro<\/jats:italic> and <jats:italic>in vivo<\/jats:italic>. Consequently, the HRHTKQRHTALH peptide might be a promising lead peptide for the development of potential angiogenic inhibitors.<\/jats:p>","DOI":"10.1038\/sigtrans.2017.10","type":"journal-article","created":{"date-parts":[[2017,5,12]],"date-time":"2017-05-12T09:41:11Z","timestamp":1494582071000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":39,"title":["A novel peptide specifically binding to VEGF receptor suppresses angiogenesis in vitro and in vivo"],"prefix":"10.1038","volume":"2","author":[{"given":"Yuan","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bifang","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Ning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delun","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenli","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhigang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xun","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,5,12]]},"reference":[{"key":"BFsigtrans201710_CR1","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.ophtha.2009.06.045","volume":"116","author":"SB Bressler","year":"2009","unstructured":"Bressler SB . Introduction: understanding the role of angiogenesis and antiangiogenic agents in age-related macular degeneration. Ophthalmology 2009; 116: S1\u2013S7.","journal-title":"Ophthalmology"},{"key":"BFsigtrans201710_CR2","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1038\/nature04478","volume":"438","author":"P Carmeliet","year":"2005","unstructured":"Carmeliet P . Angiogenesis in life, disease and medicine. Nature 2005; 438: 932\u2013936.","journal-title":"Nature"},{"key":"BFsigtrans201710_CR3","first-page":"2311","volume":"9","author":"X Lu","year":"2015","unstructured":"Lu X, Sun X . Profile of conbercept in the treatment of neovascular age-related macular degeneration. Drug Des Devel Ther 2015; 9: 2311\u20132320.","journal-title":"Drug Des Devel Ther"},{"key":"BFsigtrans201710_CR4","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.disamonth.2014.03.009","volume":"60","author":"MK Asano","year":"2014","unstructured":"Asano MK, Dray PB . Retinopathy of prematurity. Dis Mon 2014; 60: 282\u2013291.","journal-title":"Dis Mon"},{"key":"BFsigtrans201710_CR5","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1016\/j.cellsig.2007.05.013","volume":"19","author":"K Holmes","year":"2007","unstructured":"Holmes K, Roberts OL, Thomas AM, Cross MJ . Vascular endothelial growth factor receptor-2: structure, function, intracellular signalling and therapeutic inhibition. Cell Signal 2007; 19: 2003\u20132012.","journal-title":"Cell Signal"},{"key":"BFsigtrans201710_CR6","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1038\/nrd.2015.17","volume":"15","author":"N Ferrara","year":"2016","unstructured":"Ferrara N, Adamis AP . Ten years of anti-vascular endothelial growth factor therapy. Nat Rev Drug Discov 2016; 15: 385\u2013403.","journal-title":"Nat Rev Drug Discov"},{"key":"BFsigtrans201710_CR7","doi-asserted-by":"publisher","first-page":"173","DOI":"10.2174\/138945011794182674","volume":"12","author":"C Campa","year":"2011","unstructured":"Campa C, Harding SP . Anti-VEGF compounds in the treatment of neovascular age related macular degeneration. Curr Drug Targets 2011; 12: 173\u2013181.","journal-title":"Curr Drug Targets"},{"key":"BFsigtrans201710_CR8","doi-asserted-by":"crossref","first-page":"852183","DOI":"10.1155\/2012\/852183","volume":"2012","author":"K Kimoto","year":"2012","unstructured":"Kimoto K, Kubota T . Anti-VEGF agents for ocular angiogenesis and vascular permeability. J Ophthalmol 2012; 2012: 852183.","journal-title":"J Ophthalmol"},{"key":"BFsigtrans201710_CR9","doi-asserted-by":"publisher","first-page":"46668","DOI":"10.18632\/oncotarget.8694","volume":"7","author":"D Ribatti","year":"2016","unstructured":"Ribatti D . Tumor refractoriness to anti-VEGF therapy. Oncotarget 2016; 7: 46668\u201346677.","journal-title":"Oncotarget"},{"key":"BFsigtrans201710_CR10","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1056\/NEJMoa1102673","volume":"364","author":"CR Group","year":"2011","unstructured":"Group CR, Martin DF, Maguire MG, Ying GS, Grunwald JE, Fine SL et al. Ranibizumab and bevacizumab for neovascular age-related macular degeneration. N Engl J Med 2011; 364: 1897\u20131908.","journal-title":"N Engl J Med"},{"key":"BFsigtrans201710_CR11","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1016\/j.ophtha.2011.03.020","volume":"118","author":"JS Heier","year":"2011","unstructured":"Heier JS, Boyer D, Nguyen QD, Marcus D, Roth DB, Yancopoulos G et al. The 1-year results of CLEAR-IT 2, a phase 2 study of vascular endothelial growth factor trap-eye dosed as-needed after 12-week fixed dosing. Ophthalmology 2011; 118: 1098\u20131106.","journal-title":"Ophthalmology"},{"key":"BFsigtrans201710_CR12","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.1016\/j.ophtha.2011.02.018","volume":"118","author":"DV Do","year":"2011","unstructured":"Do DV, Schmidt-Erfurth U, Gonzalez VH, Gordon CM, Tolentino M, Berliner AJ et al. The DA VINCI study: phase 2 primary results of VEGF Trap-Eye in patients with diabetic macular edema. Ophthalmology 2011; 118: 1819\u20131826.","journal-title":"Ophthalmology"},{"key":"BFsigtrans201710_CR13","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1016\/j.ophtha.2010.08.008","volume":"118","author":"M Zhang","year":"2011","unstructured":"Zhang M, Zhang J, Yan M, Luo D, Zhu W, Kaiser PK et al. A phase 1 study of KH902, a vascular endothelial growth factor receptor decoy, for exudative age-related macular degeneration. Ophthalmology 2011; 118: 672\u2013678.","journal-title":"Ophthalmology"},{"key":"BFsigtrans201710_CR14","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1586\/ecp.12.81","volume":"6","author":"MW Stewart","year":"2013","unstructured":"Stewart MW . Aflibercept (VEGF Trap-Eye) for the treatment of exudative age-related macular degeneration. Expert Rev Clin Pharmacol 2013; 6: 103\u2013113.","journal-title":"Expert Rev Clin Pharmacol"},{"key":"BFsigtrans201710_CR15","doi-asserted-by":"publisher","first-page":"1740","DOI":"10.1016\/j.ophtha.2014.03.026","volume":"121","author":"X Li","year":"2014","unstructured":"Li X, Xu G, Wang Y, Xu X, Liu X, Tang S et al. Safety and efficacy of conbercept in neovascular age-related macular degeneration: results from a 12-month randomized phase 2 study: AURORA study. Ophthalmology 2014; 121: 1740\u20131747.","journal-title":"Ophthalmology"},{"key":"BFsigtrans201710_CR16","doi-asserted-by":"publisher","first-page":"1860","DOI":"10.1016\/j.ophtha.2013.01.073","volume":"120","author":"GJ Jaffe","year":"2013","unstructured":"Jaffe GJ, Martin DF, Toth CA, Daniel E, Maguire MG, Ying GS et al. Macular morphology and visual acuity in the comparison of age-related macular degeneration treatments trials. Ophthalmology 2013; 120: 1860\u20131870.","journal-title":"Ophthalmology"},{"key":"BFsigtrans201710_CR17","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1111\/cbdd.12055","volume":"81","author":"DJ Craik","year":"2013","unstructured":"Craik DJ, Fairlie DP, Liras S, Price D . The future of peptide-based drugs. Chem Biol Drug Des 2013; 81: 136\u2013147.","journal-title":"Chem Biol Drug Des"},{"key":"BFsigtrans201710_CR18","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.2174\/0929867322666150114163308","volume":"22","author":"Q Sun","year":"2015","unstructured":"Sun Q, Xu X . A promising future for peptides in ophthalmology: work effectively and smartly. Curr Med Chem 2015; 22: 1030\u20131040.","journal-title":"Curr Med Chem"},{"key":"BFsigtrans201710_CR19","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1126\/science.4001944","volume":"228","author":"GP Smith","year":"1985","unstructured":"Smith GP . Filamentous fusion phage: novel expression vectors that display cloned antigens on the virion surface. Science 1985; 228: 1315\u20131317.","journal-title":"Science"},{"key":"BFsigtrans201710_CR20","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1016\/j.drudis.2013.09.001","volume":"18","author":"M Hamzeh-Mivehroud","year":"2013","unstructured":"Hamzeh-Mivehroud M, Alizadeh AA, Morris MB, Church WB, Dastmalchi S . Phage display as a technology delivering on the promise of peptide drug discovery. Drug Discov Today 2013; 18: 1144\u20131157.","journal-title":"Drug Discov Today"},{"key":"BFsigtrans201710_CR21","doi-asserted-by":"publisher","first-page":"21837","DOI":"10.1038\/srep21837","volume":"6","author":"T Li","year":"2016","unstructured":"Li T, Tu W, Liu Y, Zhou P, Cai K, Li Z et al. A potential therapeutic peptide-based neutralizer that potently inhibits Shiga toxin 2 in vitro and in vivo. Sci Rep 2016; 6: 21837.","journal-title":"Sci Rep"},{"key":"BFsigtrans201710_CR22","doi-asserted-by":"publisher","first-page":"25406","DOI":"10.1074\/jbc.M110.201103","volume":"286","author":"V Tiwari","year":"2011","unstructured":"Tiwari V, Liu J, Valyi-Nagy T, Shukla D . Anti-heparan sulfate peptides that block herpes simplex virus infection in vivo. J Biol Chem 2011; 286: 25406\u201325415.","journal-title":"J Biol Chem"},{"key":"BFsigtrans201710_CR23","first-page":"698395","volume":"2013","author":"J Huang","year":"2013","unstructured":"Huang J, Derda R, Huang Y . Phage display informatics. Comput Math Methods Med 2013; 2013: 698395.","journal-title":"Comput Math Methods Med"},{"key":"BFsigtrans201710_CR24","first-page":"983829","volume":"2013","author":"B He","year":"2013","unstructured":"He B, Mao C, Ru B, Han H, Zhou P, Huang J . Epitope mapping of metuximab on CD147 using phage display and molecular docking. Comput Math Methods Med 2013; 2013: 983829.","journal-title":"Comput Math Methods Med"},{"key":"BFsigtrans201710_CR25","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1038\/nm1101-1249","volume":"7","author":"RJ Giordano","year":"2001","unstructured":"Giordano RJ, Cardo-Vila M, Lahdenranta J, Pasqualini R, Arap W . Biopanning and rapid analysis of selective interactive ligands. Nat Med 2001; 7: 1249\u20131253.","journal-title":"Nat Med"},{"key":"BFsigtrans201710_CR26","doi-asserted-by":"publisher","first-page":"309ra165","DOI":"10.1126\/scitranslmed.aac4882","volume":"7","author":"RL Sidman","year":"2015","unstructured":"Sidman RL, Li J, Lawrence M, Hu W, Musso GF, Giordano RJ et al. The peptidomimetic Vasotide targets two retinal VEGF receptors and reduces pathological angiogenesis in murine and nonhuman primate models of retinal disease. Sci Transl Med 2015; 7: 309ra165.","journal-title":"Sci Transl Med"},{"key":"BFsigtrans201710_CR27","doi-asserted-by":"publisher","first-page":"11393","DOI":"10.1073\/pnas.172398299","volume":"99","author":"J Holash","year":"2002","unstructured":"Holash J, Davis S, Papadopoulos N, Croll SD, Ho L, Russell M et al. VEGF-Trap: a VEGF blocker with potent antitumor effects. Proc Natl Acad Sci USA 2002; 99: 11393\u201311398.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFsigtrans201710_CR28","first-page":"1982","volume":"16","author":"Y Xu","year":"2010","unstructured":"Xu Y, Zhao H, Zheng Y, Gu Q, Ma J, Xu X . A novel antiangiogenic peptide derived from hepatocyte growth factor inhibits neovascularization in vitro and in vivo. Mol Vis 2010; 16: 1982\u20131995.","journal-title":"Mol Vis"},{"key":"BFsigtrans201710_CR29","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1016\/j.bbrc.2010.05.048","volume":"396","author":"L Su","year":"2010","unstructured":"Su L, Xu X, Zhao H, Gu Q, Zou H . In vitro and in vivo antiangiogenic activity of a novel deca-peptide derived from human tissue-type plasminogen activator kringle 2. Biochem Biophys Res Commun 2010; 396: 1012\u20131017.","journal-title":"Biochem Biophys Res Commun"},{"key":"BFsigtrans201710_CR30","doi-asserted-by":"publisher","first-page":"e16712","DOI":"10.1371\/journal.pone.0016712","volume":"6","author":"X Liu","year":"2011","unstructured":"Liu X, Lin Z, Zhou T, Zong R, He H, Liu Z et al. Anti-angiogenic and anti-inflammatory effects of SERPINA3K on corneal injury. PLoS One 2011; 6: e16712.","journal-title":"PLoS One"},{"key":"BFsigtrans201710_CR31","first-page":"349","volume":"21","author":"Y Lu","year":"2016","unstructured":"Lu Y, Zheng Y, Ai J, Xu X . Therapeutic effects of a novel PIGF-1 derived peptide, ZY-1, on corneal neovascularization in vitro and in vivo. Discov Med 2016; 21: 349\u2013361.","journal-title":"Discov Med"},{"key":"BFsigtrans201710_CR32","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1097\/ICO.0000000000000548","volume":"34","author":"Y Lu","year":"2015","unstructured":"Lu Y, Xu Y, Gu Q, Xu X . Inhibition of pathologic corneal neovascularization by topical application of a novel peptide in vivo. Cornea 2015; 34: 1295\u20131302.","journal-title":"Cornea"},{"key":"BFsigtrans201710_CR33","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1006\/exer.1997.0292","volume":"64","author":"BM Kenyon","year":"1997","unstructured":"Kenyon BM, Browne F, D'Amato RJ . Effects of thalidomide and related metabolites in a mouse corneal model of neovascularization. Exp Eye Res 1997; 64: 971\u2013978.","journal-title":"Exp Eye Res"},{"key":"BFsigtrans201710_CR34","doi-asserted-by":"publisher","first-page":"D1127","DOI":"10.1093\/nar\/gkv1100","volume":"44","author":"B He","year":"2016","unstructured":"He B, Chai G, Duan Y, Yan Z, Qiu L, Zhang H et al. BDB: biopanning data bank. Nucleic Acids Res 2016; 44: D1127\u2013D1132.","journal-title":"Nucleic Acids Res"},{"key":"BFsigtrans201710_CR35","doi-asserted-by":"publisher","first-page":"D271","DOI":"10.1093\/nar\/gkr922","volume":"40","author":"J Huang","year":"2012","unstructured":"Huang J, Ru B, Zhu P, Nie F, Yang J, Wang X et al. MimoDB 2.0: a mimotope database and beyond. Nucleic Acids Res 2012; 40: D271\u2013D277.","journal-title":"Nucleic Acids Res"},{"key":"BFsigtrans201710_CR36","doi-asserted-by":"publisher","first-page":"8279","DOI":"10.3390\/molecules15118279","volume":"15","author":"B Ru","year":"2010","unstructured":"Ru B, Huang J, Dai P, Li S, Xia Z, Ding H et al. MimoDB: a new repository for mimotope data derived from phage display technology. Molecules 2010; 15: 8279\u20138288.","journal-title":"Molecules"},{"key":"BFsigtrans201710_CR37","first-page":"101932","volume":"2010","author":"J Huang","year":"2010","unstructured":"Huang J, Ru B, Li S, Lin H, Guo FB . SAROTUP: scanner and reporter of target-unrelated peptides. J Biomed Biotechnol 2010; 2010: 101932.","journal-title":"J Biomed Biotechnol"},{"key":"BFsigtrans201710_CR38","first-page":"9175143","volume":"2016","author":"B He","year":"2016","unstructured":"He B, Kang J, Ru B, Ding H, Zhou P, Huang J . SABinder: a web service for predicting streptavidin-binding peptides. Biomed Res Int 2016; 2016: 9175143.","journal-title":"Biomed Res Int"},{"key":"BFsigtrans201710_CR39","doi-asserted-by":"publisher","first-page":"694","DOI":"10.3390\/molecules16010694","volume":"16","author":"J Huang","year":"2011","unstructured":"Huang J, Ru B, Dai P . Bioinformatics resources and tools for phage display. Molecules 2011; 16: 694\u2013709.","journal-title":"Molecules"},{"key":"BFsigtrans201710_CR40","doi-asserted-by":"publisher","first-page":"71","DOI":"10.4137\/BBI.S2745","volume":"3","author":"SS Negi","year":"2009","unstructured":"Negi SS, Braun W . Automated detection of conformational epitopes using phage display Peptide sequences. Bioinform Biol Insights 2009; 3: 71\u201381.","journal-title":"Bioinform Biol Insights"},{"key":"BFsigtrans201710_CR41","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1515\/bmt-2011-0109","volume":"57","author":"E Estephan","year":"2012","unstructured":"Estephan E, Dao J, Saab MB, Panayotov I, Martin M, Larroque C et al. SVSVGMKPSPRP: a broad range adhesion peptide. Biomed Tech 2012; 57: 481\u2013489.","journal-title":"Biomed Tech"},{"key":"BFsigtrans201710_CR42","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.ab.2004.09.048","volume":"336","author":"A Menendez","year":"2005","unstructured":"Menendez A, Scott JK . The nature of target-unrelated peptides recovered in the screening of phage-displayed random peptide libraries with antibodies. Anal Biochem 2005; 336: 145\u2013157.","journal-title":"Anal Biochem"},{"key":"BFsigtrans201710_CR43","doi-asserted-by":"publisher","first-page":"790","DOI":"10.3390\/molecules16010790","volume":"16","author":"M Vodnik","year":"2011","unstructured":"Vodnik M, Zager U, Strukelj B, Lunder M . Phage display: selecting straws instead of a needle from a haystack. Molecules 2011; 16: 790\u2013817.","journal-title":"Molecules"},{"key":"BFsigtrans201710_CR44","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.1016\/j.ophtha.2013.01.061","volume":"120","author":"PK Kaiser","year":"2013","unstructured":"Kaiser PK . Emerging therapies for neovascular age-related macular degeneration: drugs in the pipeline. Ophthalmology 2013; 120: S11\u2013S15.","journal-title":"Ophthalmology"},{"key":"BFsigtrans201710_CR45","first-page":"114rv113","volume":"3","author":"Y Cao","year":"2011","unstructured":"Cao Y, Arbiser J, D'Amato RJ, D'Amore PA, Ingber DE, Kerbel R et al. Forty-year journey of angiogenesis translational research. Sci Transl Med 2011; 3: 114rv113.","journal-title":"Sci Transl Med"},{"key":"BFsigtrans201710_CR46","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1387\/ijdb.103236yc","volume":"55","author":"Y Cao","year":"2011","unstructured":"Cao Y . Antiangiogenic cancer therapy: why do mouse and human patients respond in a different way to the same drug? Int J Dev Biol 2011; 55: 557\u2013562.","journal-title":"Int J Dev Biol"},{"key":"BFsigtrans201710_CR47","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1038\/oby.2012.87","volume":"20","author":"HM White","year":"2012","unstructured":"White HM, Acton AJ, Considine RV . The angiogenic inhibitor TNP-470 decreases caloric intake and weight gain in high-fat fed mice. Obesity 2012; 20: 2003\u20132009.","journal-title":"Obesity"},{"key":"BFsigtrans201710_CR48","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.jep.2015.12.015","volume":"178","author":"S Woo","year":"2016","unstructured":"Woo S, Yoon M, Kim J, Hong Y, Kim MY, Shin SS et al. The anti-angiogenic herbal extract from Melissa officinalis inhibits adipogenesis in 3T3-L1 adipocytes and suppresses adipocyte hypertrophy in high fat diet-induced obese C57BL\/6J mice. J Ethnopharmacol 2016; 178: 238\u2013250.","journal-title":"J Ethnopharmacol"},{"key":"BFsigtrans201710_CR49","doi-asserted-by":"publisher","first-page":"e0141612","DOI":"10.1371\/journal.pone.0141612","volume":"10","author":"BY Park","year":"2015","unstructured":"Park BY, Lee H, Woo S, Yoon M, Kim J, Hong Y et al. Reduction of adipose tissue mass by the angiogenesis inhibitor ALS-L1023 from Melissa officinalis. PLoS ONE 2015; 10: e0141612.","journal-title":"PLoS ONE"},{"key":"BFsigtrans201710_CR50","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/j.fct.2012.11.052","volume":"53","author":"H Lee","year":"2013","unstructured":"Lee H, Park D, Yoon M . Korean red ginseng (Panax ginseng) prevents obesity by inhibiting angiogenesis in high fat diet-induced obese C57BL\/6J mice. Food Chem Toxicol 2013; 53: 402\u2013408.","journal-title":"Food Chem Toxicol"},{"key":"BFsigtrans201710_CR51","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/nrd3055","volume":"9","author":"Y Cao","year":"2010","unstructured":"Cao Y . Adipose tissue angiogenesis as a therapeutic target for obesity and metabolic diseases. Nat Rev Drug Discov 2010; 9: 107\u2013115.","journal-title":"Nat Rev Drug Discov"}],"container-title":["Signal Transduction and Targeted Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/sigtrans201710.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/sigtrans201710","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/sigtrans201710","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/www.nature.com\/articles\/sigtrans201710.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,22]],"date-time":"2022-12-22T16:15:42Z","timestamp":1671725742000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/sigtrans201710"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,12]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,12,22]]}},"alternative-id":["BFsigtrans201710"],"URL":"https:\/\/doi.org\/10.1038\/sigtrans.2017.10","relation":{},"ISSN":["2059-3635"],"issn-type":[{"value":"2059-3635","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,12]]},"assertion":[{"value":"9 October 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2017","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2017","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2017","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interests","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"17010"}}